Skip to main content

Table 4 Early (30-days) results

From: Mid-term results of mitral valve repair using flexible bands versus complete rings in patients with degenerative mitral valve disease: a prospective, randomized study

  SR Group,
n = 85
FB Group,
n = 86
Р value
Hospital mortalitya, n (%) 1 (1.2) 0 0.313
ICU stay, days 2 (1–14) 2 (1–14) 0.453
Ventilation time, h 7 (0–49) 5 (1–41) 0.068
Inotropic support, h 10 (0–151) 14 (0–105) 0.591
Heart failure, n (%) 23 (27.1) 19 (22.1) 0.451
Prolonged ventilation, n (%) 14 (16.5) 15 (17.4) 0.866
ECLS, n (%) 1 (1.2) 1 (1.2) 0.993
AF Early paroxysm, n (%), 39 (45.9) 30 (34.9) 0.143
Electrical cardioversion, n (%) 7 (8.2) 3 (3.5) 0.186
Valve-related complications, n (%):
 MI, n (%) 5 (5.9) 3 (3.5) 0.459
 TIA, n (%) 4 (4.7) 0 0.042
 Stroke, n (%) 0 1 (1.2) 0.319
 AKF, n (%) 5 (5.9) 4 (4.7) 0.719
 IE, n (%) 1 (1.2) 1 (1.2) 0.993
 Ring dehiscence, n (%) 1 (1.2) 0 0.313
 Leak, n (%) 0 0
 Thrombosis, n (%) 0 0
 Other embolic events, n (%) 0 0
 Structural dysfunction, n (%) 0 0
Bleeding, n (%); 9 (10.6) 6 (7.0) 0.404
Re-exploration for bleeding, n (%) 4 (4.7) 1 (1.2) 0.169
Lymphorrhea, n (%) 0 1 (1.2) 0.319
Pacemaker implantation, n (%) 5 (5.9) 4 (4.7) 0.719
Pleural effusion, n (%) 14 (16.5) 20 (23.2) 0.266
Deep sternal infection, n (%) 0 0
Superficial infection, n (%) 1 (1.2) 1 (1.2) 0.993
Hospital stay, days 17 (9–178) 17 (7–36) 0.455
  1. SR semirigid ring, FB flexible band, ICU intensive care unit, ECLS extracorporeal life support, AF atrial fibrillation, MI myocardial infarction, TIA transient ischemic attack, AKF acute kidney failure, IE infective endocarditis
  2. ahospital death occurred 6 months after surgery